hydration benefits glp-1 receptor agonist therapy Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes Long-term Success of GLP-1s Hinges
Description
Oral formulations now lead in deal volume, accounting for nearly 45% of all transactions over the past five years
However, this requires further study
J Clin Endocrinol Metabolism
Circulation, American Heart Association, 2024 Impact of Semaglutide on fat mass, lean mass, and muscle function in patients with obesity: The SEMALEAN Study PMC, 2024 GLP-1 receptor agonists and sarcopenia: Weight loss at a cost
Incretin-based therapies
The bigger picture: GLP-1 therapies are driving innovation at the intersection of endocrinology, cardiology, and obesity managementand reshaping pharma pipelines globally
